+1 858-523-8231
Login | Register
menu
AA Blocks, Building Blocks, Catalysts, Inhibitors
Login | Register
68858-20-8,MFCD00037124
Catalog No.:AA0036N5

68858-20-8 | Fmoc-Val-OH

Pack Size
Purity
Availability
Price(USD)
Quantity
  
5g
97%
in stock  
$6.00   $4.00
- +
10g
97%
in stock  
$7.00   $5.00
- +
25g
97%
in stock  
$16.00   $11.00
- +
100g
97%
in stock  
$43.00   $30.00
- +
500g
97%
in stock  
$167.00   $117.00
- +
  • Technical Information
  • Properties
  • Upstream Synthesis Route
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA0036N5
Chemical Name:
Fmoc-Val-OH
CAS Number:
68858-20-8
Molecular Formula:
C20H21NO4
Molecular Weight:
339.3850
MDL Number:
MFCD00037124
SMILES:
O=C(N[C@H](C(=O)O)C(C)C)OCC1c2ccccc2c2c1cccc2
Properties
Properties
 
BP:
551.8°C at 760 mmHg  
Form:
Solid  
MP:
143-145 °C(lit.);  
Refractive Index:
-17.5 ° (C=1, DMF)  
Solubility:
Solubility in methanol gives very faint turbidity.  
Storage:
Keep in dry area;Room Temperature;  

Computed Properties
 
Complexity:
470  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
1  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
25  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0  
Rotatable Bond Count:
6  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
4  

Upstream Synthesis Route

[1]EuropeanJournalofInorganicChemistry,2016,vol.2016,#35,p.5427-5434

[1]Tetrahedron,2018,vol.74,#12,p.1278-1287

[1]EuropeanJournalofOrganicChemistry,2013,#21,p.4509-4513

[2]Tetrahedron,2014,vol.70,#14,p.2351-2358

[1]JournalofPharmaceuticalSciences,1994,vol.83,#7,p.999-1005

[2]Langmuir,2010,vol.26,#7,p.4990-4998

[3]Patent:WO2018/178060,2018,A1,.Locationinpatent:Page/Pagecolumn64-66

[4]JournaloftheAmericanChemicalSociety,2015,vol.137,#21,p.6932-6940

[5]Patent:US2017/247324,2017,A1,.Locationinpatent:Paragraph0284;0285

[6]Tetrahedron,2009,vol.65,#19,p.3871-3877

[7]OrganicandBiomolecularChemistry,2011,vol.9,#11,p.4182-4187

[8]JournalofControlledRelease,2012,vol.160,#3,p.618-629

[9]Patent:WO2013/67597,2013,A1,.Locationinpatent:Page/Pagecolumn80

[10]Patent:WO2014/80251,2014,A1,.Locationinpatent:Sheet16/23

[11]Patent:WO2015/21092,2015,A1,.Locationinpatent:Page/Pagecolumn36

[12]BioconjugateChemistry,2015,vol.26,#11,p.2261-2278

[13]Patent:WO2017/149077,2017,A1,.Locationinpatent:Paragraph00128-00129

[14]Patent:CN107789630,2018,A,.Locationinpatent:Paragraph0067;0068;0069

[15]Patent:WO2018/115466,2018,A1,.Locationinpatent:Paragraph00103;00124;00125

[1]TetrahedronLetters,2002,vol.43,#9,p.1661-1664

Downstream Synthesis Route
29022-11-5    68858-20-8    35661-40-6    108-24-7    198561-07-8   
Ac-Val-Asp-Phe-Gly-OH 

[1]OrganicLetters,2007,vol.9,p.2469-2472

[1]Patent:US2006/211623,2006,A1.Locationinpatent:Page/Pagecolumn9

Fmoc-Rinkresin 
  29022-11-5    68858-20-8    35661-60-0    71989-33-8    71989-23-6    71989-26-9    103213-32-7    71989-35-0    132388-59-1    96402-49-2   
Nα-(9-fluorenylmethyloxycarbonyl)-Nγ-2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl-L-arginine 
 
C175H214N21O24PolS3 

[1]JournaloftheAmericanChemicalSociety,2008,vol.130,p.14625-14633

Fmoc-Rinkresin 
  29022-11-5    68858-20-8    35661-60-0    71989-33-8    71989-23-6    71989-26-9    71989-35-0    132388-59-1    132327-80-1    96402-49-2   
Nα-(9-fluorenylmethyloxycarbonyl)-Nγ-2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl-L-arginine 
 
C131H176N19O22PolS 

[1]JournaloftheAmericanChemicalSociety,2008,vol.130,p.14625-14633

Fmoc-Rinkresin 
  29022-11-5    68858-20-8    35661-60-0    71989-23-6    71989-26-9    103213-32-7    71989-35-0    132388-59-1    96402-49-2    118358-38-6   
Nα-(9-fluorenylmethyloxycarbonyl)-Nγ-2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl-L-arginine 
 
C185H224N21O33PolS3 

[1]JournaloftheAmericanChemicalSociety,2008,vol.130,p.14625-14633

Literature

Title: Design and synthesis of new N-(fluorenyl-9-methoxycarbonyl) (Fmoc)-dipeptides as anti-inflammatory agents.

Journal: European journal of medicinal chemistry 20090501

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
Submit
SDS
Related Products of 68858-20-8
101555-63-9

101555-63-9

 101555-62-8

101555-62-8

 114360-54-2

114360-54-2

 116821-47-7

116821-47-7

 117106-20-4

117106-20-4

 117322-30-2

117322-30-2
Building Blocks
More >
Tags:68858-20-8 Molecular Formula|68858-20-8 MDL|68858-20-8 SMILES|68858-20-8 Fmoc-Val-OH
Catalog No.: AA0036N5
68858-20-8,MFCD00037124
68858-20-8 | Fmoc-Val-OH
Pack Size： 5g
Purity： 97%
in stock
$6.00 $4.00
Pack Size： 10g
Purity： 97%
in stock
$7.00 $5.00
Pack Size： 25g
Purity： 97%
in stock
$16.00 $11.00
Pack Size： 100g
Purity： 97%
in stock
$43.00 $30.00
Pack Size： 500g
Purity： 97%
in stock
$167.00 $117.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA0036N5
Chemical Name: Fmoc-Val-OH
CAS Number: 68858-20-8
Molecular Formula: C20H21NO4
Molecular Weight: 339.3850
MDL Number: MFCD00037124
SMILES: O=C(N[C@H](C(=O)O)C(C)C)OCC1c2ccccc2c2c1cccc2
Properties
BP: 551.8°C at 760 mmHg  
Form: Solid  
MP: 143-145 °C(lit.);  
Refractive Index: -17.5 ° (C=1, DMF)  
Solubility: Solubility in methanol gives very faint turbidity.  
Storage: Keep in dry area;Room Temperature;  
Complexity: 470  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 1  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 25  
Hydrogen Bond Acceptor Count: 4  
Hydrogen Bond Donor Count: 2  
Isotope Atom Count: 0  
Rotatable Bond Count: 6  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 4  
Upstream Synthesis Route
68858-20-8    71989-31-6    71989-14-5    71989-23-6    71989-38-3    109425-51-6    4474-91-3 

[1]EuropeanJournalofInorganicChemistry,2016,vol.2016,#35,p.5427-5434

503-74-2    68858-20-8    35661-39-3    158257-40-0    26305-03-3 

[1]Tetrahedron,2018,vol.74,#12,p.1278-1287

68858-20-8    103478-58-6 

[1]EuropeanJournalofOrganicChemistry,2013,#21,p.4509-4513

[2]Tetrahedron,2014,vol.70,#14,p.2351-2358

6066-82-6    68858-20-8    130878-68-1 

[1]JournalofPharmaceuticalSciences,1994,vol.83,#7,p.999-1005

[2]Langmuir,2010,vol.26,#7,p.4990-4998

[3]Patent:WO2018/178060,2018,A1,.Locationinpatent:Page/Pagecolumn64-66

[4]JournaloftheAmericanChemicalSociety,2015,vol.137,#21,p.6932-6940

[5]Patent:US2017/247324,2017,A1,.Locationinpatent:Paragraph0284;0285

[6]Tetrahedron,2009,vol.65,#19,p.3871-3877

[7]OrganicandBiomolecularChemistry,2011,vol.9,#11,p.4182-4187

[8]JournalofControlledRelease,2012,vol.160,#3,p.618-629

[9]Patent:WO2013/67597,2013,A1,.Locationinpatent:Page/Pagecolumn80

[10]Patent:WO2014/80251,2014,A1,.Locationinpatent:Sheet16/23

[11]Patent:WO2015/21092,2015,A1,.Locationinpatent:Page/Pagecolumn36

[12]BioconjugateChemistry,2015,vol.26,#11,p.2261-2278

[13]Patent:WO2017/149077,2017,A1,.Locationinpatent:Paragraph00128-00129

[14]Patent:CN107789630,2018,A,.Locationinpatent:Paragraph0067;0068;0069

[15]Patent:WO2018/115466,2018,A1,.Locationinpatent:Paragraph00103;00124;00125

68858-20-8    130878-68-1 

[1]TetrahedronLetters,2002,vol.43,#9,p.1661-1664

Downstream Synthesis Route
29022-11-5    68858-20-8    35661-40-6    108-24-7    198561-07-8   
Ac-Val-Asp-Phe-Gly-OH 

[1]OrganicLetters,2007,vol.9,p.2469-2472

C34H28N2O7 
  29022-11-5    68858-20-8    35661-60-0    35661-39-3    122889-11-6    71989-31-6    71989-18-9    103213-32-7    86060-81-3    116611-64-4    223416-45-3 

[1]Patent:US2006/211623,2006,A1.Locationinpatent:Page/Pagecolumn9

Fmoc-Rinkresin 
  29022-11-5    68858-20-8    35661-60-0    71989-33-8    71989-23-6    71989-26-9    103213-32-7    71989-35-0    132388-59-1    96402-49-2   
Nα-(9-fluorenylmethyloxycarbonyl)-Nγ-2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl-L-arginine 
 
C175H214N21O24PolS3 

[1]JournaloftheAmericanChemicalSociety,2008,vol.130,p.14625-14633

Fmoc-Rinkresin 
  29022-11-5    68858-20-8    35661-60-0    71989-33-8    71989-23-6    71989-26-9    71989-35-0    132388-59-1    132327-80-1    96402-49-2   
Nα-(9-fluorenylmethyloxycarbonyl)-Nγ-2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl-L-arginine 
 
C131H176N19O22PolS 

[1]JournaloftheAmericanChemicalSociety,2008,vol.130,p.14625-14633

Fmoc-Rinkresin 
  29022-11-5    68858-20-8    35661-60-0    71989-23-6    71989-26-9    103213-32-7    71989-35-0    132388-59-1    96402-49-2    118358-38-6   
Nα-(9-fluorenylmethyloxycarbonyl)-Nγ-2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl-L-arginine 
 
C185H224N21O33PolS3 

[1]JournaloftheAmericanChemicalSociety,2008,vol.130,p.14625-14633

Literature fold

Title: Design and synthesis of new N-(fluorenyl-9-methoxycarbonyl) (Fmoc)-dipeptides as anti-inflammatory agents.

Journal: European journal of medicinal chemistry20090501

Related Products of of 68858-20-8
101555-63-9
101555-63-9
101555-62-8
101555-62-8
114360-54-2
114360-54-2
116821-47-7
116821-47-7
117106-20-4
117106-20-4
117322-30-2
117322-30-2
Building Blocks More >
932-72-9
932-72-9
(Dichloroiodo)-benzene, tech grade
AA0036QM | MFCD00009608
64024-63-1
64024-63-1
4-[2-(Trimethylsilyl)ethynyl]morpholine
AA0036TT | MFCD05865184
61266-55-5
61266-55-5
(4,4-Dimethyloxetan-2-yl)methanol
AA0036X3 | MFCD22123255
5423-54-1
5423-54-1
4-Hydroxy-1,5-naphthyridine
AA00370A | MFCD00234402
480-22-8
480-22-8
1,8,9-Trihydroxyanthracene
AA00373F | MFCD00001250
39226-97-6
39226-97-6
2-Chloro-3-(trifluoromethyl)benzoic acid
AA00376T | MFCD00792415
61563-26-6
61563-26-6
2,3-dibromobenzaldehyde
AA0037A5 | MFCD11520724
29086-41-7
29086-41-7
1,1-Bis(bromomethyl)cyclopropane
AA0037DD | MFCD18836655
22433-68-7
22433-68-7
4-Amino-5-methylpyrimidine
AA0037GD | MFCD09909807
5570-78-5
5570-78-5
1-isopropylpiperidin-4-ol
AA0037JN | MFCD00101977
Submit
© 2017 AA BLOCKS, INC. All rights reserved.